PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
27506770-3	2016	We recently found that a small molecule 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) directly targeted annexin A7 (ANXA7) and inhibited its GTPase activity.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	93-96	annexin A7	Homo sapiens	128-133
27506770-3	2016	We recently found that a small molecule 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) directly targeted annexin A7 (ANXA7) and inhibited its GTPase activity.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	40-91	annexin A7	Homo sapiens	116-126
27506770-3	2016	We recently found that a small molecule 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) directly targeted annexin A7 (ANXA7) and inhibited its GTPase activity.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	40-91	annexin A7	Homo sapiens	128-133
30911960-0	2019	Effects of annexin A7 inhibitor-ABO on the expression and distribution of long noncoding RNA-CERNA1 in vascular endothelial cells apoptosis.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	32-35	annexin A7	Homo sapiens	11-21
30911960-8	2019	And the annexin A7 inhibitor, ABO (6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine), not only increased the expression of CERNA1 by TIA-1, but also specifically improved its cytoplasm distribution proportion so as to inhibit the apoptosis of VECs.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	30-33	annexin A7	Homo sapiens	8-18
30911960-8	2019	And the annexin A7 inhibitor, ABO (6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine), not only increased the expression of CERNA1 by TIA-1, but also specifically improved its cytoplasm distribution proportion so as to inhibit the apoptosis of VECs.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	30-33	TIA1 cytotoxic granule associated RNA binding protein	Homo sapiens	136-141
30911960-8	2019	And the annexin A7 inhibitor, ABO (6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine), not only increased the expression of CERNA1 by TIA-1, but also specifically improved its cytoplasm distribution proportion so as to inhibit the apoptosis of VECs.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	35-86	annexin A7	Homo sapiens	8-18
30911960-8	2019	And the annexin A7 inhibitor, ABO (6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine), not only increased the expression of CERNA1 by TIA-1, but also specifically improved its cytoplasm distribution proportion so as to inhibit the apoptosis of VECs.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	35-86	TIA1 cytotoxic granule associated RNA binding protein	Homo sapiens	136-141
27506770-3	2016	We recently found that a small molecule 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) directly targeted annexin A7 (ANXA7) and inhibited its GTPase activity.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	93-96	annexin A7	Homo sapiens	116-126
22966033-9	2012	CRP was highest initially among patients with simultaneous ABO + ABA and among those with complicated outcomes, and was lower at the transition to oral therapy in the complicated outcome group (1.5 vs 2.1 mg/dL; P = .012).	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	59-62	C-reactive protein	Homo sapiens	0-3
24052074-3	2013	We recently found a small chemical molecule (6-amino-2, 3-dihydro-3-hydroxymethyl-1, 4-benzoxazine, ABO) that could inhibit oxidized low-density lipoprotein (oxLDL)-induced apoptosis and promote autophagy in VECs, and further identified ABO as an inhibitor of annexin A7 (ANXA7) GTPase.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	45-98	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase)	Mus musculus	100-103
24052074-3	2013	We recently found a small chemical molecule (6-amino-2, 3-dihydro-3-hydroxymethyl-1, 4-benzoxazine, ABO) that could inhibit oxidized low-density lipoprotein (oxLDL)-induced apoptosis and promote autophagy in VECs, and further identified ABO as an inhibitor of annexin A7 (ANXA7) GTPase.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	45-98	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase)	Mus musculus	237-240
24052074-3	2013	We recently found a small chemical molecule (6-amino-2, 3-dihydro-3-hydroxymethyl-1, 4-benzoxazine, ABO) that could inhibit oxidized low-density lipoprotein (oxLDL)-induced apoptosis and promote autophagy in VECs, and further identified ABO as an inhibitor of annexin A7 (ANXA7) GTPase.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	45-98	annexin A7	Mus musculus	260-270
24052074-3	2013	We recently found a small chemical molecule (6-amino-2, 3-dihydro-3-hydroxymethyl-1, 4-benzoxazine, ABO) that could inhibit oxidized low-density lipoprotein (oxLDL)-induced apoptosis and promote autophagy in VECs, and further identified ABO as an inhibitor of annexin A7 (ANXA7) GTPase.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	45-98	annexin A7	Mus musculus	272-277
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	63-114	fibroblast growth factor 2	Homo sapiens	212-242
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	63-114	fibroblast growth factor 2	Homo sapiens	244-248
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	116-119	fibroblast growth factor 2	Homo sapiens	212-242
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	116-119	fibroblast growth factor 2	Homo sapiens	244-248